Cabergoline: Difference between revisions
| [checked revision] | [pending revision] |
MDElliottMD (talk | contribs) Pharmacopedia: remove contraindications parameter |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Antiparkinsonian Medicines -> Antiparkinsonism agents |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 22: | Line 22: | ||
| dosing = | | dosing = | ||
| effects = | | effects = | ||
| interactions = | | interactions = <pharmaInteractions/> | ||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 31: | Line 31: | ||
}} | }} | ||
[[Category:Antiparkinsonism agents]] | |||
[[Category:Antiparkinsonian]] | [[Category:Antiparkinsonian]] | ||
[[Category:Dopamine Agonists]] | |||
Latest revision as of 00:35, 22 May 2026
Antiparkinsonian, Dopamine agonist
Cabergoline
Dostinex
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antiparkinsonian, Dopamine agonist
Common uses
Pharmacy
Pharmacology
Purported mechanism
D2 receptor agonist